Curevac establishes fully-owned company dedicated to advancing the rna printer(r)

The rna printer (r) is curevac's integrated and automated manufacturing solution for rna vaccines and therapeutics curevac rna printer gmbh to provide dedicated infrastructure to accelerate development and broaden application range of the rna printer (r) dr. markus bergmann appointed as general manager for curevac rna printer gmbh tÜbingen, germany and boston, ma / accesswire / march 1, 2022 / curevac n.v. (nasdaq:cvac), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mrna"), today announced that it has established curevac rna printer gmbh, a fully-owned curevac company to advance the rna printer(r).
CVAC Ratings Summary
CVAC Quant Ranking